UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities

Neuropharmacology, 2023-06, Vol.230, p.109467-109467, Article 109467

2023

Volltextzugriff (PDF)

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs

Neuropharmacology, 2023-08, Vol.233, p.109528-109528, Article 109528

2023

Volltextzugriff (PDF)

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

Neuropharmacology, 2022-11, Vol.218, p.109220-109220, Article 109220

2022

Volltextzugriff (PDF)

The National Cancer Institute’s Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps

Journal of the National Cancer Institute. Monographs, 2017-11, Vol.2017 (52)

2017

Volltextzugriff (PDF)

Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies

Nutrition and cancer, 2015-07, Vol.67 (5), p.730-740

2015

Volltextzugriff (PDF)

A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer

Clinical cancer research, 2004-10, Vol.10 (20), p.6764-6769

2004

Volltextzugriff (PDF)

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

Lung cancer (Amsterdam, Netherlands), 2001-03, Vol.31 (2-3), p.203-212

2001

Volltextzugriff (PDF)

Complementary and Alternative Medicine Use Among Overweight and Obese Cancer Survivors in the United States

Integrative cancer therapies, 2015-11, Vol.14 (6), p.503-514

2015

Volltextzugriff (PDF)

Phase I with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.129-129

2020

Volltextzugriff (PDF)

A Vasoactive Intestinal Peptide Antagonist Inhibits Non-Small Cell Lung Cancer Growth

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4345-4349

1993

Volltextzugriff (PDF)

Phase 1 with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS2645-TPS2645

2019

Volltextzugriff (PDF)

Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4886-4891

1995

Volltextzugriff (PDF)

The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treated With Unconventional Therapies in India

Integrative cancer therapies, 2013-09, Vol.12 (5), p.385-392

2013

Volltextzugriff (PDF)

What freedom?: Reflections of a working journalist

From Terrorism to Television, 2021, p.163-176

1, 2021

Volltextzugriff (PDF)

National Cancer Institute Best Case Series program

Integrative cancer therapies, 2009-06, Vol.8 (2), p.113-114

2009

Volltextzugriff (PDF)

Letter to the Editor

Integrative cancer therapies, 2009-06, Vol.8 (2), p.113-114

2009

Volltextzugriff (PDF)

Letter to the Editor

Integrative cancer therapies, 2009-06, Vol.8 (2), p.113-114

2009

Volltextzugriff (PDF)

Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells

Peptides (New York, N.Y. : 1980), 1993-03, Vol.14 (2), p.241-246

1993

Volltextzugriff (PDF)

Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (2), p.281-285

1994

Volltextzugriff (PDF)

Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice

Cancer letters, 2000-07, Vol.155 (2), p.121-127

2000

Volltextzugriff (PDF)

Survey of complementary and alternative medicine practitioners regarding cancer management and research

Journal of the Society for Integrative Oncology, 2009, Vol.7 (1), p.26

2009

Volltextzugriff (PDF)

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

Breast cancer research and treatment, 1999-07, Vol.56 (2), p.177-186

1999

Volltextzugriff (PDF)

Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo

Journal of cellular biochemistry, 1996, Vol.63 (S24), p.269-275

1996

Volltextzugriff (PDF)

Neuromedin B stimulates arachidonic acid release, c-fos gene expression, and the growth of C6 glioma cells

Peptides (New York, N.Y. : 1980), 1995, Vol.16 (6), p.1133-1140

1995

Volltextzugriff (PDF)

BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth

Life sciences (1973), 1995, Vol.56 (7), p.521-529

1995

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

The National Cancer Institute’s Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps

Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies

A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

Complementary and Alternative Medicine Use Among Overweight and Obese Cancer Survivors in the United States

Phase I with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors

A Vasoactive Intestinal Peptide Antagonist Inhibits Non-Small Cell Lung Cancer Growth

Phase 1 with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors

Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells

The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treated With Unconventional Therapies in India

What freedom?: Reflections of a working journalist

National Cancer Institute Best Case Series program

Letter to the Editor

Letter to the Editor

Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells

Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells

Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice

Survey of complementary and alternative medicine practitioners regarding cancer management and research

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo

Neuromedin B stimulates arachidonic acid release, c-fos gene expression, and the growth of C6 glioma cells

BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth

Suchergebnisse filtern